BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30926095)

  • 1. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving molecular genetic landscape in acute myeloid leukaemia.
    Sanders MA; Valk PJ
    Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
    Li S; Mason CE; Melnick A
    Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
    Wouters BJ; Delwel R
    Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.
    Pan D; Rampal R; Mascarenhas J
    Blood Adv; 2020 Mar; 4(5):970-982. PubMed ID: 32150613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driver mutations in acute myeloid leukemia.
    Kishtagari A; Levine RL; Viny AD
    Curr Opin Hematol; 2020 Mar; 27(2):49-57. PubMed ID: 31972687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the understanding and treatment of acute myeloid leukemia.
    Watts J; Nimer S
    F1000Res; 2018; 7():. PubMed ID: 30135719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
    Chianese U; Papulino C; Megchelenbrink W; Tambaro FP; Ciardiello F; Benedetti R; Altucci L
    Semin Cancer Biol; 2023 Jul; 92():84-101. PubMed ID: 37003397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities.
    Zhao X; Liu HQ; Wang LN; Yang L; Liu XL
    Semin Cancer Biol; 2022 Aug; 83():121-135. PubMed ID: 33242577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic dysregulation in myelodysplastic syndrome].
    Sashida G; Iwama A
    Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecular abnormalities and clonal architecture in AML: from reciprocal translocations to whole-genome sequencing.
    Graubert TA; Brunner AM; Fathi AT
    Am Soc Clin Oncol Educ Book; 2014; ():e334-40. PubMed ID: 24857122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics in acute myeloid leukemia.
    Plass C; Oakes C; Blum W; Marcucci G
    Semin Oncol; 2008 Aug; 35(4):378-87. PubMed ID: 18692688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of paediatric acute myeloid leukaemia.
    Jones L; McCarthy P; Bond J
    Br J Haematol; 2020 Jan; 188(1):63-76. PubMed ID: 31804725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.
    Chaudry SF; Chevassut TJ
    Biomed Res Int; 2017; 2017():5473197. PubMed ID: 28286768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.
    Li S; Chen X; Wang J; Meydan C; Glass JL; Shih AH; Delwel R; Levine RL; Mason CE; Melnick AM
    Cancer Discov; 2020 Dec; 10(12):1934-1949. PubMed ID: 32938585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.